ada.enesco, Author at European Medical Journal - Page 52 of 65

Novel Procedure May Eliminate Insulin Dependency in Type 2 Diabetes - UEG Week 2024

Pioneering research presented at UEG Week 2024 has revealed a new treatment approach for Type 2 diabetes that could reduce the need for insulin therapy.

New Imaging Technique Shows Promise for Personalised Oesophageal Cancer Treatment – UEG Week 2024

A study presented at UEGW 2024 is exploring a breakthrough imaging technique aimed at improving treatment outcomes for patients with locally advanced oesophageal cancer.

Study Identifies Pre-diagnostic Antibody Signatures in IBD – UEG Week 2024

A groundbreaking study presented at UEG Week 2024 has revealed distinct antibody responses in Crohn’s disease and ulcerative colitis apparent years before diagnosis.

Austrian Experts Call for Nationwide Colorectal Cancer Screening - UEG Week 2024

Leading health experts at UEG Week 2024 are calling for the implementation of a national, quality-assured colorectal cancer screening programme for individuals aged 45–75.

Swedish Study Reveals Falling Melanoma Rates in Young Adults

Recent trends in melanoma incidence and mortality in Sweden reveal promising changes, particularly among younger age groups

Oral Bacteria Linked to Increased Head and Neck Cancer Risk

A recent study has examined the potential link between the oral microbiome and the development of head and neck squamous cell cancer

Acne Prevalence Increasing Among Adolescents and Young Adults

Acne vulgaris is rising globally, with a 2021 study showing increasing prevalence, incidence, and disability-adjusted life years, particularly among young people aged 10-24.

Global Prevalence of Sexually Transmitted Diseases: EADV 2024

New research presented at EADV 2024 highlights the widespread prevalence of STIs across different regions, age groups, and socio-economic factors, highlighting the critical need for improved prevention and management strategies worldwide.

Impact of Atopic Dermatitis Depends on Age of Onset: EADV 2024

New research presented at EADV 2024 highlights the significant impact of atopic dermatitis on psychological and social well-being.

Tumour-Specific Antibodies Detect Early Melanoma: EADV 2024

A new method for early melanoma detection, using tumour-specific antibody profiling, was presented at the EADV Congress 2024.